The approval will allow eligible patients to receive the maximum weekly dose of Wegovy in a single injection.
Follow CnD's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.
You can even combine different feeds with the feed for CnD.
Subscribing and unsubscribing is fast, easy and risk free.
The whole service is free of cost.
CnD: Chemist+Druggist | Community pharmacy news, analysis and CPD | Est. 1859